Novel Molecules Private Limited - Company Profile

It is a chemicals and materials private limited company based in Khed, Maharashtra, India, established in 2019.
2019 Khed, Maharashtra, India Active
Last Updated:
Access Report
About Novel Molecules Private Limited

Novel Molecules Private Limited, a active private limited company, was established on 10 December 2019 in Khed, Maharashtra, India. Engaging in industrial chemicals within the trade sector, it holds CIN: U24297PN2019PTC188316. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Sahil Pradeep Mulaokar (Director), Pradeep Digamber Mulaokar (Additional Director). Past directors included Sandesh Jagannath Shinde. It holds ₹2.98 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. B-45, Midc, Lote, Parshuram,, Khed, Maharashtra, 415722.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24297PN2019PTC188316

  • Registration Number

    188316

  • Incorporation Date

    10 December 2019

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 6 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.98 M
  • Revenue Growth **** 166.79%
  • Profit Growth **** 392.68%
  • Ebitda **** 756.40%
  • Net Worth 200.48%
  • Total Assets **** 53.90%
Company report

Novel Molecules Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novel Molecules Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Novel Molecules Private Limited?
Current Directors
Name Designation Appointment Date Status
Sahil Pradeep Mulaokar Director 10 Dec 2019 Current
Pradeep Digamber Mulaokar Additional Director 14 Aug 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Aug 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novel Molecules.

Novel Molecules Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 166.79% increase. The company also saw a substantial improvement in profitability, with a 392.68% increase in profit. The company's net worth Soared by an impressive increase of 200.48%.

Novel Molecules revenue growth over time
Novel Molecules profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 166.79%
*******
*******
*******
*******
Revenue from Operations
*******
 166.99%
*******
*******
*******
*******
Total Assets
*******
 53.90%
*******
*******
*******
*******
Profit or Loss
*******
 392.68%
*******
*******
*******
*******
Net Worth
*******
 200.48%
*******
*******
*******
*******
EBITDA
*******
 756.40%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novel Molecules?

In 2020, Novel Molecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,975,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.30 Cr
Latest Charge Details
Date Lender Amount Status
05 Oct 2021 Others ₹1.80 M Open
07 Sep 2021 Others ₹1.18 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Novel Molecules?

Unlock and access historical data on people associated with Novel Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novel Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novel Molecules's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novel Molecules
Recent Activity within the Organization
  • Annual General Meeting

    The activity Novel Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Novel Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Charges

    A charge with Others amounted to Rs. 1.80 M with Charge ID 100502702 was registered on 05 Oct 2021. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 1.18 M with Charge ID 100484026 was registered on 07 Sep 2021. was documented.

  • Director Appointment

    Pradeep Digamber Mulaokar was appointed as a Additional Director was appointed as a Additional Director on 14 Aug 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.

  • Director Appointment

    The activity Sahil Pradeep Mulaokar was appointed as a Director was appointed as a Director on 10 Dec 2019 & has been associated with this company since 6 years 2 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novel Molecules Private Limited?

The CIN of Novel Molecules Private Limited is U24297PN2019PTC188316.

Where is Novel Molecules Private Limited headquartered?

Novel Molecules Private Limited is headquartered at Plot No. B-45, Midc, Lote, Parshuram,, Khed, Maharashtra, 415722.

When was Novel Molecules Private Limited incorporated?

Novel Molecules Private Limited was incorporated on 10 December 2019.

Who are the current directors of Novel Molecules Private Limited?

The current directors of Novel Molecules Private Limited are

What is the primary industry of Novel Molecules Private Limited?

The primary industry of Novel Molecules Private Limited is Trade.

Is Novel Molecules Private Limited a listed company?

Novel Molecules Private Limited is unlisted.

What is the capital structure of Novel Molecules Private Limited?

The authorized capital of Novel Molecules Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available